S D Silberstein
Overview
Explore the profile of S D Silberstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
4585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan H, Hopkins M, Goldberg J, Silberstein S
Acta Neurol Scand
. 2015 Dec;
134(4):277-83.
PMID: 26626126
Background: A simple screening tool may potentially help the migraine diagnosis in a primary care setting. The use of single-item tests, such as stripe pattern hypersensitivity test and self-reported bothersome...
2.
Young W, Silberstein S, Lipton R
J Back Musculoskelet Rehabil
. 2014 Feb;
11(1):3-17.
PMID: 24572382
Aging is accompanied by a decline in the incidence of most primary headache disorders and an increase in the incidence of organic causes of headache. Headaches that begin after age...
3.
Aurora S, Dodick D, Diener H, DeGryse R, Turkel C, Lipton R, et al.
Acta Neurol Scand
. 2013 Oct;
129(1):61-70.
PMID: 24107267
Objective: Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical program assessed efficacy and safety of onabotulinumtoxinA (BOTOX(®)) for prophylaxis...
4.
Silberstein S, Newman L, Marmura M, Nahas S, Farr S
Curr Med Res Opin
. 2013 Mar;
29(7):861-7.
PMID: 23514092
Many efficacy endpoints have been used in clinical trials of acute migraine pharmacotherapy. Headache response or headache relief (i.e., moderate/severe pain reduced to mild/no pain) at a single, specified time-point,...
5.
Silberstein S
Clin Pharmacol Ther
. 2012 Dec;
93(1):78-85.
PMID: 23212108
Migraine is a primary brain disorder resulting from altered modulation of normal sensory stimuli and trigeminal nerve dysfunction. The second edition of the International Classification of Headache Disorders (ICHD-2) defines...
6.
Young W, Silberstein S
J Neurosurg Sci
. 2012 Nov;
56(4):307-12.
PMID: 23111291
Occipital nerve stimulation may be effective for primary headache disorders. Four studies, including two double-blind show, stimulation-controlled studies that were performed for chronic migraine showed evidence of benefit. A separate...
7.
Holland S, Silberstein S, Freitag F, Dodick D, Argoff C, Ashman E
Neurology
. 2012 Apr;
78(17):1346-53.
PMID: 22529203
Objective: To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: Are nonsteroidal anti-inflammatory drugs (NSAIDs) or other complementary treatments effective for migraine...
8.
Silberstein S, Holland S, Freitag F, Dodick D, Argoff C, Ashman E
Neurology
. 2012 Apr;
78(17):1337-45.
PMID: 22529202
Objective: To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: What pharmacologic therapies are proven effective for migraine prevention? Methods: The authors...
9.
Silberstein S, Dodick D, Lindblad A, Holroyd K, Harrington M, Mathew N, et al.
Neurology
. 2012 Mar;
78(13):976-84.
PMID: 22377815
Objective: To assess the efficacy and safety of adding propranolol to topiramate in chronic migraine subjects inadequately controlled with topiramate alone. Methods: This was a double-blind, placebo-controlled, randomized clinical trial...
10.
Lipton R, Varon S, Grosberg B, McAllister P, Freitag F, Aurora S, et al.
Neurology
. 2011 Sep;
77(15):1465-72.
PMID: 21956721
Objective: To assess the effects of treatment with onabotulinumtoxinA (Botox, Allergan, Inc., Irvine, CA) on health-related quality of life (HRQoL) and headache impact in adults with chronic migraine (CM). Methods:...